210 related articles for article (PubMed ID: 20460894)
1. Cytochrome P450 2D6 as a model antigen.
Christen U; Holdener M; Hintermann E
Dig Dis; 2010; 28(1):80-5. PubMed ID: 20460894
[TBL] [Abstract][Full Text] [Related]
2. Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis.
Ehser J; Holdener M; Christen S; Bayer M; Pfeilschifter JM; Hintermann E; Bogdanos D; Christen U
J Autoimmun; 2013 May; 42():39-49. PubMed ID: 23200317
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of autoimmune hepatic fibrogenesis induced by an adenovirus encoding the human liver autoantigen cytochrome P450 2D6.
Hintermann E; Ehser J; Bayer M; Pfeilschifter JM; Christen U
J Autoimmun; 2013 Aug; 44():49-60. PubMed ID: 23809878
[TBL] [Abstract][Full Text] [Related]
4. Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection.
Holdener M; Hintermann E; Bayer M; Rhode A; Rodrigo E; Hintereder G; Johnson EF; Gonzalez FJ; Pfeilschifter J; Manns MP; Herrath Mv; Christen U
J Exp Med; 2008 Jun; 205(6):1409-22. PubMed ID: 18474629
[TBL] [Abstract][Full Text] [Related]
5. Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model.
Hintermann E; Holdener M; Bayer M; Loges S; Pfeilschifter JM; Granier C; Manns MP; Christen U
J Autoimmun; 2011 Nov; 37(3):242-53. PubMed ID: 21795021
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse model.
Müller P; Messmer M; Bayer M; Pfeilschifter JM; Hintermann E; Christen U
J Autoimmun; 2016 May; 69():51-8. PubMed ID: 26924542
[TBL] [Abstract][Full Text] [Related]
7. Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis.
Longhi MS; Hussain MJ; Kwok WW; Mieli-Vergani G; Ma Y; Vergani D
Hepatology; 2011 Feb; 53(2):536-47. PubMed ID: 21274874
[TBL] [Abstract][Full Text] [Related]
8. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
Zierden M; Kühnen E; Odenthal M; Dienes HP
Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
[TBL] [Abstract][Full Text] [Related]
9. The CYP2D6 animal model: how to induce autoimmune hepatitis in mice.
Hintermann E; Ehser J; Christen U
J Vis Exp; 2012 Feb; (60):. PubMed ID: 22331063
[TBL] [Abstract][Full Text] [Related]
10. A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens.
Lapierre P; Djilali-Saiah I; Vitozzi S; Alvarez F
Hepatology; 2004 Apr; 39(4):1066-74. PubMed ID: 15057911
[TBL] [Abstract][Full Text] [Related]
11. The influence of genetic predisposition and autoimmune hepatitis inducing antigens in disease development.
Hardtke-Wolenski M; Dywicki J; Fischer K; Hapke M; Sievers M; Schlue J; Anderson MS; Taubert R; Noyan F; Manns MP; Jaeckel E
J Autoimmun; 2017 Mar; 78():39-45. PubMed ID: 27974250
[TBL] [Abstract][Full Text] [Related]
12. Effects of adenovirus-induced hepatocyte damage on chronic bile duct inflammation in a sclerosing cholangitis mouse model.
Fuchs S; Bayer M; Taubert R; Manns MP; Pfeilschifter JM; Christen U; Hintermann E
Liver Int; 2019 Dec; 39(12):2330-2340. PubMed ID: 31225929
[TBL] [Abstract][Full Text] [Related]
13. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
Manns MP; Obermayer-Straub P
Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
[TBL] [Abstract][Full Text] [Related]
14. Chemical induced inflammation of the liver breaks tolerance and results in autoimmune hepatitis in Balb/c mice.
Chi G; Pei JH; Ma QY; Ru YX; Feng ZH
Immunol Lett; 2020 Feb; 218():44-50. PubMed ID: 31794800
[TBL] [Abstract][Full Text] [Related]
15. The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model.
Yuksel M; Xiao X; Tai N; Vijay M; Gülden E; Beland K; Lapierre P; Alvarez F; Hu Z; Colle I; Ma Y; Wen L
Clin Exp Immunol; 2016 Nov; 186(2):164-176. PubMed ID: 27414259
[TBL] [Abstract][Full Text] [Related]
16. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes.
Klein R; Zanger UM; Berg T; Hopf U; Berg PA
Clin Exp Immunol; 1999 Nov; 118(2):290-7. PubMed ID: 10540193
[TBL] [Abstract][Full Text] [Related]
17. A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens.
Sugimura T; Obermayer-Straub P; Kayser A; Braun S; Loges S; Alex B; Lüttig B; Johnson EF; Manns MP; Strassburg CP
Autoimmunity; 2002 Dec; 35(8):501-13. PubMed ID: 12765476
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactivity to various human cytochrome P450 proteins of sera from patients with autoimmune hepatitis, chronic hepatitis B, and chronic hepatitis C.
Miyakawa H; Kitazawa E; Kikuchi K; Fujikawa H; Kawaguchi N; Abe K; Matsushita M; Matsushima H; Igarashi T; Hankins RW; Kako M
Autoimmunity; 2000; 33(1):23-32. PubMed ID: 11204250
[TBL] [Abstract][Full Text] [Related]
19. Development of a New Murine Model of Type 2 Autoimmune Hepatitis Using a Human Liver Protein.
Thomas-Dupont P; Grube-Pagola P; Izaguirre-Hernández IY; Hernández-Flores KG; Sánchez-Marce EE; Cano-Contreras AD; Remes-Troche JM; Vivanco-Cid H
Am J Pathol; 2022 Jan; 192(1):21-30. PubMed ID: 34717895
[TBL] [Abstract][Full Text] [Related]
20. Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment.
Dalekos GN; Wedemeyer H; Obermayer-Straub P; Kayser A; Barut A; Frank H; Manns MP
J Hepatol; 1999 Mar; 30(3):366-75. PubMed ID: 10190716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
